Author

Jean-Claude Michaud

Institution: Sanofi (France)

Observed institution: Sanofi (France)

OpenAlex ID: A5111935971

Inhibition of long-term potentiation in rat hippocampal slices by anandamide and WIN55212-2: reversal by SR141716 A, a selective antagonist of CB1 cannabinoid receptors

1995 · Jean-Paul Terranova, Jean-Claude Michaud, et al. · Naunyn-Schmiedeberg s Archives of Pharmacology · 208

SR 57227A: a potent and selective agonist at central and peripheral 5-HT3 receptors in vitro and in vivo

1993 · André Bachy, Michel Héaulme, et al. · European Journal of Pharmacology · 92

SSR240600 [(R)-2-(1-{2-[4-{2-[3,5-Bis(trifluoromethyl)phenyl]acetyl}-2-(3,4-dichlorophenyl)-2-morpholinyl]ethyl}-4-piperidinyl)-2-methylpropanamide], a Centrally Active Nonpeptide Antagonist of the Tachykinin Neurokinin 1 Receptor: II. Neurochemical and Behavioral Characterization

2002 · Régis Steinberg, Richard Alonso, et al. · Journal of Pharmacology and Experimental Therapeutics · 41

Biochemical and pharmacological activities of SSR 146977, a new potent nonpeptide tachykinin NK3 receptor antagonist

2002 · Xavier Emonds-Alt, Vincenzo Proietto, et al. · Canadian Journal of Physiology and Pharmacology · 38

Effects of neurotensin receptor antagonists on the firing rate of rat ventral pallidum neurons

2000 · Jean-Claude Michaud, Christiane Gueudet, et al. · Neuroreport · 13

SR 46559A: a novel and potent muscarinic compound with no cholinergic syndrome

1993 · Jean-Paul Kan, Régis Steinberg, et al. · Psychopharmacology · 11

EEG effects of IV infusion of pentylenetetrazol in rats: A model for screening and classifying antiepileptic compounds

1985 · Vincent Santucci, Mich�le Fournier, et al. · Psychopharmacology · 7

Works count: 7

Citation count: 410

H-index: 7

I10-index: 6